NCT00183807View on ClinicalTrials.gov

A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

February 28, 2006

Study Completion Date

March 31, 2008

Conditions
Esophageal Cancer
Interventions
DRUG

irinotecan, cisplatin, celecoxib

Trial Locations (1)

90033

U.S.C. / Norris Comprehensive Cancer Center, Los Angeles

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of Southern California

OTHER